Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Pyridine derivatives >  4-BOC-1-(5-BROMO-2-PYRIDYL)PIPERAZINE

4-BOC-1-(5-BROMO-2-PYRIDYL)PIPERAZINE

Basic information Safety Supplier Related

4-BOC-1-(5-BROMO-2-PYRIDYL)PIPERAZINE Basic information

Product Name:
4-BOC-1-(5-BROMO-2-PYRIDYL)PIPERAZINE
Synonyms:
  • 1-Boc-4-(5-bromo-2-pyridinyl)-piperazine
  • 5-Bromo-2-[4-(N-Boc)piperazin-1-yl]pyridine
  • 1-Piperazinecarboxylic acid, 4-(5-bromo-2-pyridinyl)-, 1,1-dimethylethyl ester
  • 2-(4-BOC-piperazino)-5-bromopyridine
  • t-Butyl 4-(5-bromopyridin-2-yl)piperazine-1-carboxylate
  • Palbociclib Impurity C : Trifluoroacetic acid salt
  • Palbociclib impurity C
  • 4-Boc-1-(5-bromo-2-pyridyl)piperazine 97%
CAS:
153747-97-8
MF:
C14H20BrN3O2
MW:
342.23
Product Categories:
  • Organohalides
  • Pyridine
  • piperazines
  • pharmacetical
  • alkyl bromide
Mol File:
153747-97-8.mol
More
Less

4-BOC-1-(5-BROMO-2-PYRIDYL)PIPERAZINE Chemical Properties

Melting point:
83-87 °C (lit.)
Boiling point:
433.0±45.0 °C(Predicted)
Density 
1.372±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
pka
6.06±0.29(Predicted)
form 
Powder
color 
White to yellow
Water Solubility 
Soluble in water.
InChI
InChI=1S/C14H20BrN3O2/c1-14(2,3)20-13(19)18-8-6-17(7-9-18)12-5-4-11(15)10-16-12/h4-5,10H,6-9H2,1-3H3
InChIKey
DSLVSFMWCDGZIL-UHFFFAOYSA-N
SMILES
N1(C(OC(C)(C)C)=O)CCN(C2=NC=C(Br)C=C2)CC1
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
25-36/37/38
Safety Statements 
26-36/37/39-45
RIDADR 
UN 2811 6.1/PG 3
WGK Germany 
3
HazardClass 
6.1
HS Code 
2933599590
More
Less

4-BOC-1-(5-BROMO-2-PYRIDYL)PIPERAZINE Usage And Synthesis

Uses

4-Boc-1-(5-bromo-2-pyridyl)piperazine is used as active pharmaceutical ingredient.

Synthesis

624-28-2

57260-71-6

153747-97-8

General procedure for the synthesis of 4-Boc-1-(5-bromo-2-pyridinyl)piperazine from 2,5-dibromopyridine and N-BOC-piperazine: 2,5-dibromopyridine (2 g, 10.7 mmol), sodium tert-butoxide (1.6 g, 16.6 mmol), xantphos (400 mg, 0.7 mmol) and toluene (100 mL) and purged with argon for 5 min. Subsequently, tert-butyl piperazine-1-carboxylate (3.4 g, 14.30 mmol) and Pd2(dba)3 (200 mg, 0.21 mmol) were added to the reaction system, and the reaction was heated at 80 °C for 4 h (TLC monitoring showed complete consumption of raw materials). Upon completion of the reaction, the reaction mixture was diluted with EtOAc (200 mL), water (100 mL) was added, filtered through a bed of diatomaceous earth, and the filter bed was washed with EtOAc (2 x 30 mL). The organic phases were combined, washed with brine (50 mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure to give the crude product. The crude product was purified by silica gel column chromatography (100-200 mesh, 50 g, 10-20% EtOAc-hexane gradient elution) to give tert-butyl 4-(5-bromo-2-pyridinyl)piperazine-1-carboxylate (3 g, 82%) as a yellow solid.LCMS (ESI+): m/z: 342.57 [M+H]+.

References

[1] Organic Letters, 2003, vol. 5, # 24, p. 4611 - 4614
[2] Patent: WO2018/125961, 2018, A1. Location in patent: Page/Page column 123
[3] Patent: WO2007/20888, 2007, A1. Location in patent: Page/Page column 45-46
[4] Patent: US2006/293310, 2006, A1. Location in patent: Page/Page column 5

4-BOC-1-(5-BROMO-2-PYRIDYL)PIPERAZINESupplier

Aloespharm Co., Ltd. Gold
Tel
021-20960837
Email
market@aloespharm.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
PharmaBlock Sciences (Nanjing),Inc.
Tel
025-86918202 4000255188
Email
sales@pharmablock.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
Alfa Aesar
Tel
400-6106006
Email
saleschina@alfa-asia.com